What is HC Wainwright’s Estimate for Edap Tms Q4 Earnings?

Edap Tms S.A. (NASDAQ:EDAP) – Research analysts at HC Wainwright issued their Q4 2026 earnings per share estimates for shares of Edap Tms in a report released on Friday, May 16th. HC Wainwright analyst S. Ramakanth expects that the medical equipment provider will earn ($0.08) per share for the quarter. HC Wainwright currently has a “Buy” rating and a $19.00 price target on the stock. The consensus estimate for Edap Tms’ current full-year earnings is ($0.60) per share. HC Wainwright also issued estimates for Edap Tms’ FY2029 earnings at $0.31 EPS.

A number of other analysts also recently commented on the company. StockNews.com assumed coverage on Edap Tms in a research report on Thursday, May 15th. They set a “hold” rating for the company. Jefferies Financial Group reaffirmed a “hold” rating and set a $2.00 price target (down from $8.00) on shares of Edap Tms in a research report on Friday, April 4th. Finally, Piper Sandler downgraded Edap Tms from an “overweight” rating to a “neutral” rating in a research report on Thursday, May 15th.

Edap Tms Stock Performance

Shares of Edap Tms stock opened at $1.90 on Monday. The company has a market cap of $71.04 million, a PE ratio of -2.92 and a beta of 0.13. Edap Tms has a 52 week low of $1.26 and a 52 week high of $6.58. The business has a 50 day moving average price of $1.90 and a 200-day moving average price of $2.23. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, May 15th. The medical equipment provider reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.04). The firm had revenue of $16.37 million during the quarter, compared to the consensus estimate of $16.56 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%.

Hedge Funds Weigh In On Edap Tms

A number of large investors have recently made changes to their positions in EDAP. Banque Transatlantique SA boosted its holdings in shares of Edap Tms by 7,063.7% in the first quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock worth $1,324,000 after acquiring an additional 720,499 shares during the period. Scoggin Management LP purchased a new position in shares of Edap Tms in the first quarter worth about $686,000. Jane Street Group LLC increased its holdings in shares of Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 73,361 shares during the period. Schonfeld Strategic Advisors LLC increased its holdings in shares of Edap Tms by 48.5% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after buying an additional 52,500 shares during the period. Finally, Millennium Management LLC increased its holdings in shares of Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 33,558 shares during the period. 62.74% of the stock is owned by institutional investors.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.